Open Label Non-Randomized Phase II Study Exploring ``Chemo-Free'' Treatment Association with Idelalisib plus Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis o

Affiliation auteurs!!!! Error affiliation !!!!
TitreOpen Label Non-Randomized Phase II Study Exploring ``Chemo-Free'' Treatment Association with Idelalisib plus Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis o
Type de publicationJournal Article
Year of Publication2019
AuteursTomowiak C, Desseaux K, Poulain S, Herbaux C, Perrot A, Mahe B, Morel P, Tournilhac O, Lepretre S, Aurran T, Villemagne B, Casasnovas O, Nollet D, Dreyfus B, Chevret S, Leblond V
JournalBLOOD
Volume134
Date PublishedNOV 13
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2019-122826